Free Trial

Monte Rosa Therapeutics (GLUE) Insider Trading & Ownership

Monte Rosa Therapeutics logo
$19.81 -0.58 (-2.84%)
As of 10:25 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Monte Rosa Therapeutics (NASDAQ:GLUE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$797.09K
Get GLUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GLUE Insider Buying and Selling by Quarter

Monte Rosa Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/9/2026Sell5,845$17.69$103,398.05  
3/4/2026
Edmund Dunn
Insider
Sell139$17.96$2,496.44  
3/2/2026
Edmund Dunn
Insider
Sell536$17.50$9,380.00  
3/2/2026Sell5,466$17.92$97,950.72  
2/27/2026
Edmund Dunn
Insider
Sell25,164$18.10$455,468.40  
1/7/2026Sell5,466$23.49$128,396.34  
(Data available from 1/1/2013 forward)

GLUE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Monte Rosa Therapeutics includes Chandra P Leo, Edmund Dunn, Markus Warmuth, Philip Nickson, and Versant Venture Capital Vi, L.. Learn more on insiders at GLUE.

6.90% of Monte Rosa Therapeutics stock is owned by insiders. Learn more on GLUE's insider holdings.

The following insider purchased GLUE shares in the last 24 months: Chandra P Leo ($58,400.00).

Insiders have purchased a total of 10,000 GLUE shares in the last 24 months for a total of $58,400.00 bought.

The following insiders have sold GLUE shares in the last 24 months: Edmund Dunn ($473,511.14), Markus Warmuth ($226,347.06), Philip Nickson ($103,398.05), and Versant Venture Capital Vi, L. ($11,573,438.42).

Insiders have sold a total of 1,817,948 Monte Rosa Therapeutics shares in the last 24 months for a total of $12,376,694.67 sold.



This page (NASDAQ:GLUE) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners